Multiple Microbial and Mammalian Target

The designation "Multiple Microbial & Mammalian Targets" is a non-specific term used in high-throughput screening, computational biology, or drug discovery contexts to refer collectively to several distinct molecular entities from both microbial and mammalian origins that are evaluated as possible points of therapeutic intervention. Such lists may include enzymes, receptors, ion channels, or other biomolecules from bacteria, viruses, and mammalian hosts, and are used for evaluating broad-acting or multitarget drugs, or for systems biology analysis[1][8]. This is not a single, defined molecular target, but rather a placeholder phrase indicating the presence of multiple and disparate biological macromolecules under study[1]. Because of its vague and collective nature, it cannot be mapped to a canonical molecule/receptor. This entry lacks the specificity required for structured annotations and should be replaced by individual, well-defined molecular entity names (such as "DNA gyrase," "Mitogen-activated protein kinase 1," etc.), each of which can then be characterized with proper canonical names, biological functions, disease relevance, and associated drugs.